Navigation Links
U.S. FDA Clears Bayer HealthCare's CONTOUR® Next EZ Blood Glucose Monitoring System

TARRYTOWN, N.Y., April 18, 2012 /PRNewswire/ -- Bayer HealthCare today announced that the U.S. Food and Drug Administration (FDA) has cleared its CONTOUR® Next EZ, a new blood glucose monitoring (BGM) system for use in the United States.  CONTOUR Next EZ includes an easy-to-use meter and test strip sensors with innovative technology for advanced accuracy.  Bayer's new BGM system is being introduced on a market-by-market basis and is currently available in other countries as CONTOUR XT.  In the U.S., CONTOUR Next EZ will be available this summer.

(Logo: )

With Bayer's proprietary new blood glucose sensor technology, the CONTOUR Next EZ system delivers advanced accuracy that notably exceeds the requirements of ISO 15197:2003.  The proprietary electrochemical mediator and meter algorithm utilized in the CONTOUR Next EZ blood glucose monitoring system provides a stable, high signal-to-noise ratio that facilitates accurate determination of blood glucose readings, even at low blood glucose levels.  The new technology also ensures that the system remains accurate under a wide range of storage conditions, corrects for common errors and is not affected by hematocrit or many common interfering substances in the blood (e.g. acetaminophen, vitamin C).

The new CONTOUR Next EZ system was tested in a number of studies[1],[2],[3],[4],[5] around the globe in which it consistently showed excellent performance in the hands of healthcare providers as well as patients.

Bayer HealthCare
The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials.  Bayer HealthCare, a subgroup of Bayer AG with annual sales of EUR 16.913 billion (2010), is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany.  The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions.  Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide.  Bayer HealthCare has a global workforce of 55,700 employees (Dec 31, 2010) and is represented in more than 100 countries.  Find more information at

Susan Yarin

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management.  Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here.  These factors include those discussed in Bayer's public reports which are available on the Bayer website at  The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

[1] Bailey T, Wallace J, Parkes J L, Pardo S, Schachner H C, Castro R, Simmons D, Chu A. Performance of a New Blood Glucose Test Strip; poster presented at the 71st Scientific Sessions of the American Diabetes Association (ADA), June 24-28, 2011, San Diego, USA. [Sponsored by Bayer]

[2] Lemke C, Petruschke Th, Wallace J, Pardo S, Parkers J, Matthaei S; Performance Evaluation of a Novel Blood Glucose Monitoring System; presented at the 11th Annual Diabetes Technology Meeting of the Diabetes Technology Society (DTS), October 27-29, 2011, Burlingame, California, USA. [Sponsored by Bayer]

[3] David A S, Wallace J, Parkes J L, Pardo S, Schachner H C, Castro R, Chu A, Bailey T; poster presented at the World Diabetes Congress of the International Diabetes Federation (IDF), December 4-8, 2011, Dubai [Sponsored by Bayer]

[4] Warchal-Windham ME, Castro R, Chu A; Accuracy evaluation of the CONTOUR®XT blood glucose meter; poster presented at the 5th International Conference on Advanced Technologies and Treatments for Diabetes, Barcelona, February 8-11, 2012.

[5] Alcaraz J, Rico N, Petruschke Th, Bedini JL; Performance Evaluation of a Novel Blood Glucose Monitoring System: CONTOUR®XT; poster presented at the 5th International Conference on Advanced Technologies and Treatments for Diabetes, Barcelona, February 8-11, 2012 . [Sponsored by Bayer]

SOURCE Bayer HealthCare
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. FDA Clears Advanced Test for Monitoring Metastatic Colorectal Cancer
2. FDA Clears ExAblate Fertility Enhancement Study in Women With Uterine Fibroids
3. FDA Clears the Pathwork(R) Tissue of Origin Test for Hard-To-Identify Tumors
4. U.S. Food and Drug Administration Clears Way for Multi-Center Clinical Trial of IDEV Technologies SUPERA Peripheral Stent
5. FDA Clears a Test for Ovarian Cancer
6. Private Investment Firm Czura Thornton Today Introduces Clearstone Central Laboratories as the Newest Member of the Czura Thornton Life Science Group
7. U.S. Food and Drug Administration Clears Alcatel-Lucent Remote Patient Monitoring Solution for Sale in the United States
8. FDA Clears the First Rapid Test to Detect Bacteria in Pooled Platelets
9. FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology
10. FDA Clears the Fenwal Amicus(R) Separator System for Collecting Platelets in New Additive Solution
11. FDA Clears Three Additional Antimicrobials for Use on TREK Sensititre(R) In Vitro Diagnostic (IVD) MIC Susceptibility Plates: Minocycline and Telavancin Used to Treat MRSA and Other Infections; and Tigecycline, Now Cleared for Streptococcus Pneumoni
Post Your Comments:
(Date:11/24/2015)...  Array BioPharma Inc. (Nasdaq: ARRY ) ... Ron Squarer , will present at the Piper ... public is welcome to participate in the conference ... Jaffray Annual Healthcare ConferencePresenter:  , Ron Squarer, Chief ... Eastern Time Webcast: , ...
(Date:11/24/2015)... , 24. November 2015 ... Breathing Pacemaker Systems, ist erfreut, die Berufung ... Consultant bekannt geben zu können. ...   --> Foto - ... (Schweden). Von 1984-1986 war er Fellow ...
(Date:11/24/2015)... COMMACK, N.Y. , Nov. 24, 2015 ... Pacemaker System, is pleased to announce the appointment of ... ... and pediatric cardiology at Children,s Hospital, Uppsala University, Uppsala ... . From 1984-1986, he was a fellow at the ...
Breaking Medicine Technology:
(Date:11/25/2015)... MN (PRWEB) , ... November 25, 2015 , ... ... launched offering factory direct sauna parts and accessories. , Sauna accessories help ... of the bather’s style and personality. From basic styles for the purist looking ...
(Date:11/25/2015)... ... November 25, 2015 , ... According to an ... is being more and more widely heralded as a breakthrough for performing hernia repairs. ... has over traditional laparoscopic surgery is that it can greatly reduce the pain that ...
(Date:11/25/2015)... ... November 25, 2015 , ... The McHenry County law ... successful appellate decision obtained by Attorneys Francisco J. Botto and Alex C. Wimmer. Attorneys ... Workers’ Compensation Comm’n, 2015 IL App (2d) 130884WC. , According to court documents, Adcock ...
(Date:11/25/2015)... ... November 25, 2015 , ... Brillianteen, McGaw YMCA’s student-produced musical ... its 65th Anniversary Brillianteen Revue, scheduled for March 4-6, 2016. Auditions for this ... Brillianteen has been a treasured tradition for numerous families in the Evanston community. ...
(Date:11/25/2015)... Spring, Md (PRWEB) , ... November 25, 2015 ... ... Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible ... history of this disease. The Periwinkle Pioneers, nominated by the public, will receive ...
Breaking Medicine News(10 mins):